N-(4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-((7-METHYL-7-AZASPIRO(3.5)NONAN-2-YL)METHOXY)QUINAZOLIN-6-YL)ACRYLAMIDE DIHYDROCHLORIDE MONOHYDRATE
UNII Q5797S12KX

Substance Identification & Data

This profile provides standardized clinical and technical data for N-(4-(3-chloro-4-fluorophenylamino)-7-((7-methyl-7-azaspiro(3.5)nonan-2-yl)methoxy)quinazolin-6-yl)acrylamide Dihydrochloride Monohydrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q5797S12KX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2102413-86-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q5797S12KX

CAS Registry Number

2102413-86-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N-(4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-((7-METHYL-7-AZASPIRO(3.5)NONAN-2-YL)METHOXY)QUINAZOLIN-6-YL)ACRYLAMIDE DIHYDROCHLORIDE MONOHYDRATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C27H29ClFN5O2.2ClH.H2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WECAWHHJAJJXBQ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

139593523

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O.c1(c(cc2c(c1)c(ncn2)Nc3ccc(c(c3)Cl)F)OCC4CC5(C4)CCN(CC5)C)NC(C=C)=O.Cl.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-(4-(3-chloro-4-fluorophenylamino)-7-((7-methyl-7-azaspiro(3.5)nonan-2-yl)methoxy)quinazolin-6-yl)acrylamide Dihydrochloride Monohydrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.